Xiong Z Ruan Selected Research

Membrane Proteins (Integral Membrane Proteins)

1/2018	CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
1/2017	Suppression of CD36 attenuates adipogenesis with a reduction of P2X7 expression in 3T3-L1 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiong Z Ruan Research Topics

Disease

25	Inflammation (Inflammations) 01/2022 - 01/2003
14	Non-alcoholic Fatty Liver Disease 01/2023 - 09/2008
8	Atherosclerosis 01/2023 - 07/2005
7	Neoplasms (Cancer) 12/2022 - 12/2005
6	Insulin Resistance 01/2021 - 06/2011
6	Obesity 06/2020 - 12/2005
6	Hepatoblastoma 10/2016 - 09/2008
5	Fatty Liver 01/2023 - 04/2012
5	Hyperlipidemias (Hyperlipidemia) 01/2021 - 07/2005
4	Chronic Renal Insufficiency 01/2021 - 12/2009
4	Fibrosis (Cirrhosis) 12/2017 - 10/2011
3	Metabolic Diseases (Metabolic Disease) 04/2023 - 12/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 02/2014
2	Neoplasm Metastasis (Metastasis) 10/2022 - 12/2018
2	Hypercholesterolemia 03/2022 - 01/2017
2	Atherosclerotic Plaque (Atheroma) 06/2021 - 01/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2017
2	Platelet Glycoprotein IV Deficiency 01/2020 - 01/2017
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2019 - 12/2018
2	Carcinogenesis 12/2018 - 01/2017
2	Alcoholic Fatty Liver 01/2018 - 06/2017
2	Hyperglycemia 10/2015 - 12/2013
2	Vascular System Injuries 12/2009 - 08/2008
1	Cholangitis 01/2023
1	Hypoxia (Hypoxemia) 12/2022
1	Hepatocellular Carcinoma (Hepatoma) 03/2022
1	Bites and Stings (Sting) 01/2022
1	Hyperphosphatemia 01/2021
1	Pathologic Processes 01/2021
1	Uremia 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021

Drug/Important Bio-Agent (IBA)

27	LipidsIBA 01/2023 - 01/2003
15	CholesterolIBA 03/2022 - 07/2005
12	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 01/2014
10	Caseins (Casein)FDA Link 01/2016 - 09/2008
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2016
5	Sirolimus (Rapamycin)FDA Link 10/2015 - 07/2005
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2012
4	Interleukin-6 (Interleukin 6)IBA 01/2023 - 05/2011
4	Scavenger Receptors (Scavenger Receptor)IBA 10/2022 - 10/2011
4	ApolipoproteinsIBA 10/2016 - 07/2005
3	Glucose (Dextrose)FDA LinkGeneric 04/2023 - 12/2005
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 09/2008
3	Nonesterified Fatty Acids (NEFA)IBA 01/2022 - 06/2011
3	InflammasomesIBA 06/2021 - 06/2017
3	Apolipoproteins E (ApoE)IBA 06/2021 - 10/2011
3	Insulin (Novolin)FDA Link 01/2020 - 12/2013
3	Biomarkers (Surrogate Marker)IBA 12/2017 - 05/2014
3	CytokinesIBA 05/2015 - 04/2012
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2014 - 09/2007
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2023 - 01/2017
2	LigandsIBA 01/2023 - 01/2021
2	Interleukin-1beta (Interleukin 1 beta)IBA 01/2023 - 09/2008
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 09/2008
2	Olive OilIBA 03/2019 - 12/2018
2	Choline (Choline Chloride)IBA 10/2018 - 06/2017
2	Methionine (L-Methionine)FDA Link 10/2018 - 06/2017
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018 - 01/2017
2	Advanced Glycation End ProductsIBA 12/2017 - 07/2011
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2017 - 12/2005
2	TOR Serine-Threonine KinasesIBA 10/2015 - 04/2014
2	Liver X ReceptorsIBA 01/2015 - 09/2008
2	LDL Receptors (LDL Receptor)IBA 01/2015 - 10/2011
2	oxidized low density lipoproteinIBA 01/2013 - 05/2012
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2012 - 03/2003
1	Caspase 8 (Caspase-8)IBA 01/2023
1	Adenosine Triphosphatases (ATPase)IBA 01/2023
1	Alanine Transaminase (SGPT)IBA 01/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023
1	Chloroquine (Aralen)FDA LinkGeneric 01/2023
1	Cysteine (L-Cysteine)FDA Link 01/2023
1	Caspase 3 (Caspase-3)IBA 01/2023
1	Lysosomal-Associated Membrane Protein 1IBA 01/2023
1	Class B Scavenger ReceptorsIBA 01/2023
1	Qa-SNARE Proteins (Syntaxin)IBA 01/2023
1	R-SNARE Proteins (Vesicle-Associated Membrane Protein)IBA 01/2023
1	SNARE Proteins (SNAREs)IBA 01/2023
1	UbiquitinIBA 01/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023
1	LipopolysaccharidesIBA 01/2023
1	Lysophospholipase (Phospholipase B)IBA 01/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Sorafenib (BAY 43-9006)FDA Link 03/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Sterol Regulatory Element Binding ProteinsIBA 01/2022
1	Acyl Coenzyme A (Acyl CoA)IBA 01/2022
1	InterferonsIBA 01/2022
1	SterolsIBA 06/2021
1	Small Interfering RNA (siRNA)IBA 01/2021
1	mannosyl-oligosaccharide 1,3 - 1,6-alpha-mannosidaseIBA 01/2021
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2021
1	MannosidasesIBA 01/2021
1	Cre recombinaseIBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	MTOR InhibitorsIBA 01/2021
1	SU 6656IBA 01/2021

Therapy/Procedure

1	Immunotherapy 10/2022